Live feed
Filing
SC 13G
SC 13G0000935836-21-000342·Ovid Therapeutics Inc.
Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Security class unavailable · CUSIP: 690469101
Event date: 2021-04-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,500,000
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-21-000342
- Form type
- SC 13G
- Filer
- Ovid Therapeutics Inc.
- CIK
- CIK 1636651
- Filed
- Apr 29, 2021
- Reporting period
- Apr 20, 2021
- Description
- Schedule 13G beneficial ownership